Literature DB >> 23015284

Disseminated intravascular coagulation: a review for the internist.

Marcel Levi1, Tom van der Poll.   

Abstract

Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation, leading to widespread deposition of fibrin in the circulation. Recent knowledge on important pathogenetic mechanisms that may lead to DIC has resulted in novel preventive and therapeutic approaches to patients with DIC. The diagnosis of DIC can be made by sensitive laboratory tests; however, most of these tests are not readily available in a clinical setting. A reliable diagnosis can also be made on the basis of a small series of laboratory tests that can be combined in a scoring algorithm. The cornerstone of the management of DIC is the specific and vigorous treatment of the underlying disorder. Strategies aimed at the inhibition of coagulation activation may theoretically be justified and have been found beneficial in experimental and clinical studies. These strategies comprise inhibition of tissue factor-mediated activation of coagulation or restoration of physiological anticoagulant pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23015284     DOI: 10.1007/s11739-012-0859-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  42 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 2.  Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.

Authors:  M Levi; E de Jonge; T van der Poll
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC.

Authors:  Hideo Wada; Tsuyoshi Hatada; Kohji Okamoto; Toshimasa Uchiyama; Kazuo Kawasugi; Toshihiko Mayumi; Satoshi Gando; Shigeki Kushimoto; Yoshinobu Seki; Seiji Madoiwa; Takashi Okamura; Cheng Hock Toh
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

4.  Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period.

Authors:  Marcel Levi
Journal:  Thromb Res       Date:  2009       Impact factor: 3.944

Review 5.  Disseminated intravascular coagulation due to malignancy.

Authors:  R W Colman; R N Rubin
Journal:  Semin Oncol       Date:  1990-04       Impact factor: 4.929

6.  Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.

Authors:  Evert de Jonge; Philip W Friederich; George P Vlasuk; William E Rote; Margaretha B Vroom; Marcel Levi; Tom van der Poll
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Application of the Japanese Association for Acute Medicine disseminated intravascular coagulation diagnostic criteria for patients at an early phase of trauma.

Authors:  Atsushi Sawamura; Mineji Hayakawa; Satoshi Gando; Nobuhiko Kubota; Masahiro Sugano; Takeshi Wada; Ken-ichi Katabami
Journal:  Thromb Res       Date:  2009-08-03       Impact factor: 3.944

8.  Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.

Authors:  S Gando; Y Nakanishi; I Tedo
Journal:  Crit Care Med       Date:  1995-11       Impact factor: 7.598

9.  Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated).

Authors:  Marcel Levi; Mitchell Levy; Mark D Williams; Ivor Douglas; Antonio Artigas; Massimo Antonelli; Duncan Wyncoll; Jonathan Janes; Frank V Booth; Dazhe Wang; David P Sundin; William L Macias
Journal:  Am J Respir Crit Care Med       Date:  2007-06-07       Impact factor: 21.405

Review 10.  Tissue factor expression by monocytes: regulation and pathophysiological roles.

Authors:  B Osterud
Journal:  Blood Coagul Fibrinolysis       Date:  1998-03       Impact factor: 1.276

View more
  29 in total

1.  The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database.

Authors:  Atsuhiko Murata; Kohji Okamoto; Toshihiko Mayumi; Keiji Muramatsu; Shinya Matsuda
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

Review 2.  Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.

Authors:  Arturo J Martí-Carvajal; Vidhu Anand; Ivan Solà
Journal:  Cochrane Database Syst Rev       Date:  2015-06-24

Review 3.  THE ENDOTHELIUM IN SEPSIS.

Authors:  Can Ince; Philip R Mayeux; Trung Nguyen; Hernando Gomez; John A Kellum; Gustavo A Ospina-Tascón; Glenn Hernandez; Patrick Murray; Daniel De Backer
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

4.  Diagnostic and Prognostic Value of Plasma Factor V Activity and Parameters in Thrombin Generation for Disseminated Intravascular Coagulation in Patients with Hematological Malignancies.

Authors:  Hai-Ming Kou; Xiao-Ping Zhang; Man-Zhi Wang; Jun Deng; Heng Mei; Yu Hu
Journal:  Curr Med Sci       Date:  2019-07-25

5.  Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation.

Authors:  Manzhi Wang; Haiming Kou; Jun Deng; Huafang Wang; Tao Guo; Heng Mei; Yu Hu
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 6.  Could Biomarkers Direct Therapy for the Septic Patient?

Authors:  Clark R Sims; Trung C Nguyen; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2016-02-08       Impact factor: 4.030

7.  Observational study to compare antithrombin and thrombomodulin for disseminated intravascular coagulation.

Authors:  Atsuhiko Murata; Kohji Okamoto; Toshihiko Mayumi; Keiji Muramatsu; Shinya Matsuda
Journal:  Int J Clin Pharm       Date:  2014-12-17

8.  A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia.

Authors:  Trung C Nguyen; Francisca Gushiken; Juliana I Correa; Jing-Fei Dong; Swapan K Dasgupta; Perumal Thiagarajan; Miguel A Cruz
Journal:  Thromb Res       Date:  2015-03-03       Impact factor: 3.944

Review 9.  Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.

Authors:  Trung C Nguyen; Miguel A Cruz; Joseph A Carcillo
Journal:  Crit Care Clin       Date:  2015-08-07       Impact factor: 3.598

10.  The effects of sepsis on endothelium and clinical implications.

Authors:  Elena V Dolmatova; Keke Wang; Rohan Mandavilli; Kathy K Griendling
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.